SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-20-012354
Filing Date
2020-11-24
Accepted
2020-11-23 21:23:44
Documents
15

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2548534
2 GRAPHIC g10330g00n89.jpg GRAPHIC 136497
3 GRAPHIC g10330g00q79.jpg GRAPHIC 160175
4 GRAPHIC g10330g01y89.jpg GRAPHIC 148980
5 GRAPHIC g10330g15s86.jpg GRAPHIC 43622
6 GRAPHIC g10330g22w41.jpg GRAPHIC 104813
7 GRAPHIC g10330g24b25.jpg GRAPHIC 142433
8 GRAPHIC g10330g28s34.jpg GRAPHIC 60763
9 GRAPHIC g10330g29x51.jpg GRAPHIC 123425
10 GRAPHIC g10330g32g54.jpg GRAPHIC 160501
11 GRAPHIC g10330g34k16.jpg GRAPHIC 176883
12 GRAPHIC g10330g36r58.jpg GRAPHIC 53783
13 GRAPHIC g10330g61a61.jpg GRAPHIC 83278
14 GRAPHIC g10330g82g52.jpg GRAPHIC 124101
15 GRAPHIC g10330g87s14.jpg GRAPHIC 112053
  Complete submission text file 0000950123-20-012354.txt   4791564
Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-03819 | Film No.: 201339719
SIC: 2834 Pharmaceutical Preparations